(Reuters) – Laboratory Corporation of America Holdings said it would buy Sequenom Inc, a maker of non-invasive prenatal tests for reproductive health, for about $371 million, including debt. The $2.40 per share cash offer, which has a total equity value of $302 million, represents a 182% premium to Sequenom’s Tuesday close. Sequenom’s shares rose 177% […]
Two accused in insider trading of molecular diagnostics stocks
The federal Securities & Exchange Commission charged a Baltimore business consultant and his uncle in Cleveland of an insider trading scheme that netted the pair more than $600,000.
UPDATE: Sequenom raises $84 million in public offering
Sequenom Inc.’s (NSDQ:SQNM) $84 million public offering this week was the latest in a series of large public funding rounds for genomic analysis companies.*
The San Diego-based company develops molecular diagnostics technologies for "translational research, oncology, agricultural genomics and in vitro diagnostics for prenatal and retinal disorders," according to its website.
